Peapack Gladstone Financial Corp Organon & Co. Transaction History

Peapack Gladstone Financial Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$16.59 - $23.77 $212,069 - $303,851	-12,783 Reduced 52.91%	11,377 $197,000
Q2 2023 Aug 14, 2023	SELL	$19.27 - $24.63 $29,116 - $37,215	-1,511 Reduced 5.89%	24,160 $502,000
Q1 2023 May 15, 2023	SELL	$21.42 - $32.08 $34,636 - $51,873	-1,617 Reduced 5.93%	25,671 $605,000
Q4 2022 Feb 14, 2023	SELL	$23.31 - $28.61 $74,335 - $91,237	-3,189 Reduced 10.46%	27,288 $762,000
Q3 2022 Nov 10, 2022	SELL	$23.4 - $34.25 $134,362 - $196,663	-5,742 Reduced 15.85%	30,477 $714,000
Q2 2022 Aug 12, 2022	SELL	$31.66 - $38.9 $38,941 - $47,847	-1,230 Reduced 3.28%	36,219 $1.22 Million
Q1 2022 May 16, 2022	SELL	$30.45 - $39.36 $123,078 - $159,093	-4,042 Reduced 9.74%	37,449 $1.31 Million
Q4 2021 Feb 15, 2022	SELL	$28.67 - $37.13 $164,021 - $212,420	-5,721 Reduced 12.12%	41,491 $1.27 Million
Q3 2021 Nov 15, 2021	SELL	$28.63 - $35.64 $163,763 - $203,860	-5,720 Reduced 10.81%	47,212 $1.55 Million
Q2 2021 Aug 16, 2021	BUY	$28.45 - $38.0 $1.51 Million - $2.01 Million	52,932 New	52,932 $1.6 Million

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Peapack Gladstone Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Peapack Gladstone Financial Corp with notifications on news.